Alzheimer Disease: Dimebon Results, Part II
Hopes for Alzheimer’s Drug Are Dashed
By ANDREW POLLACK
Published: March 4, 2010
"The drug, called Dimebon, failed in its first late-stage clinical trial, dealing a blow to patients with Alzheimer’s and the companies developing the treatment, Medivation and Pfizer."
Read the full article